Oral Recombinant Methioninase, Combined With Oral Caffeine and Injected Cisplatinum, Overcome Cisplatinum-Resistance and Regresses Patient-derived Orthotopic Xenograft Model of Osteosarcoma-Reference-Cited by-同舟云学术

Oral Recombinant Methioninase, Combined With Oral Caffeine and Injected Cisplatinum, Overcome Cisplatinum-Resistance and Regresses Patient-derived Orthotopic Xenograft Model of Osteosarcoma

Published:2019-09 Issue:9 Volume:39 Page:4653-4657
ISSN:0250-7005
Container-title:Anticancer Research
language:en
Short-container-title:Anticancer Res

Author:

HIGUCHI TAKASHI,OSHIRO HIROMICHI,MIYAKE KENTARO,SUGISAWA NORIHIKO,HAN QINGHONG,TAN YUYING,PARK JUNHO,ZHANG ZHIYING,RAZMJOOEI SAHAR,YAMAMOTO NORIO,HAYASHI KATSUHIRO,KIMURA HIROAKI,MIWA SHINJI,IGARASHI KENTARO,BOUVET MICHAEL,CHAWLA SANT P.,SINGH SHREE RAM,TSUCHIYA HIROYUKI,HOFFMAN ROBERT M.

Publisher

Anticancer Research USA Inc.

Subject

Cancer Research,Oncology,General Medicine

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of methioninase for cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

2. Amicis Omnia Sunt Communia: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity;Pharmaceuticals;2024-06-05

3. DNA-Binding Agent Trabectedin Combined With Recombinant Methioninase Is Synergistic to Decrease Fibrosarcoma Cell Viability and Induce Nuclear Fragmentation But Not Synergistic on Normal Fibroblasts;Anticancer Research;2024-05-31

4. Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts;Anticancer Research;2024-02-29

5. Engineered Methioninase-Expressing Tumor-Targeting Salmonella Typhimurium A1-R Inhibits Syngeneic-Cancer Mouse Models by Depleting Tumor Methionine;2024